AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27

Authors: Sharma, RA Steward, WP West, KP Hemingway, D
Citation: Ra. Sharma et al., Toxic megacolon: remember cytomegalovirus, HOSP MED, 62(3), 2001, pp. 178-179

Authors: Sharma, RA McLelland, HR Hill, KA Ireson, CR Euden, SA Manson, MM Pirmohamed, M Marnett, LJ Gescher, AJ Steward, WP
Citation: Ra. Sharma et al., Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer, CLIN CANC R, 7(7), 2001, pp. 1894-1900

Authors: Levitt, NC Eskens, FALM O'Byrne, KJ Propper, DJ Denis, LJ Owen, SJ Choi, L Foekens, JA Wilner, S Wood, JM Nakajima, M Talbot, DC Steward, WP Harris, AL Verweij, J
Citation: Nc. Levitt et al., Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer, CLIN CANC R, 7(7), 2001, pp. 1912-1922

Authors: Sharma, RA Ireson, CR Verschoyle, RD Hill, KA Williams, ML Leuratti, C Manson, MM Marnett, LJ Steward, WP Gescher, A
Citation: Ra. Sharma et al., Effects of dietary curcumin on glutathione S-transferase and malomdialdehyde-DNA adducts in rat liver and colon mucosa: Relationship with drug levels, CLIN CANC R, 7(5), 2001, pp. 1452-1458

Authors: Sharma, RA Manson, MM Gescher, A Steward, WP
Citation: Ra. Sharma et al., Colorectal cancer chemoprevention: biochemical targets and clinical development of promising agents, EUR J CANC, 37(1), 2001, pp. 12-22

Authors: Sharma, RA Symonds, RP O'Byrne, KJ Cheater, F Abrams, KR Steward, WP
Citation: Ra. Sharma et al., Involving patients in treatment decisions: Can we learn from clinical trials?, CL ONCOL-UK, 13(5), 2001, pp. 328-332

Authors: Thomas, AL O'Byrne, K Furber, L Jeffery, K Steward, WP
Citation: Al. Thomas et al., A phase II study of Caelyx, liposomal doxorubicin: lack of activity in patients with advanced gastric cancer, CANC CHEMOT, 48(4), 2001, pp. 266-268

Authors: Sharma, RA Eatock, MM Twelves, CJ Brown, G McLelland, HR Clayton, KT O'Byrne, KJ Moyses, C Carmichael, J Steward, WP
Citation: Ra. Sharma et al., Bioavailability study of oral and intravenous OGT 719, a novel nucleoside analogue with preferential activity in the liver, CANC CHEMOT, 48(3), 2001, pp. 197-201

Authors: Sharma, RA Gescher, A Plastaras, JP Leuratti, C Singh, R Gallacher-Horley, B Offord, E Marnett, LJ Steward, WP Plummer, SM
Citation: Ra. Sharma et al., Cyclooxygenase-2, malondialdehyde and pyrimidopurinone adducts of deoxyguanosine in human colon cells, CARCINOGENE, 22(9), 2001, pp. 1557-1560

Authors: Sharma, RA Gescher, AJ O'Byrne, KJ Steward, WP
Citation: Ra. Sharma et al., Familiar drugs may prevent cancer, POSTG MED J, 77(910), 2001, pp. 492-497

Authors: O'Byrne, KJ Schally, AV Thomas, A Carney, DN Steward, WP
Citation: Kj. O'Byrne et al., Somatostatin, its receptors and analogs, in lung cancer, CHEMOTHERA, 47, 2001, pp. 78-108

Authors: Ireson, C Orr, S Jones, DJL Verschoyle, R Lim, CK Luo, JL Howells, L Plummer, S Jukes, R Williams, M Steward, WP Gescher, A
Citation: C. Ireson et al., Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E-2 production, CANCER RES, 61(3), 2001, pp. 1058-1064

Authors: Thomas, AL Steward, WP
Citation: Al. Thomas et Wp. Steward, Marimastat: the clinical development of a matrix metalloproteinase inhibitor, EXPERT OP I, 9(12), 2000, pp. 2913-2922

Authors: O'Byrne, KJ Dalgleish, AG Browning, MJ Steward, WP Harris, AL
Citation: Kj. O'Byrne et al., The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease, EUR J CANC, 36(2), 2000, pp. 151-169

Authors: Thomas, AL Cox, G Sharma, RA Steward, WP Shields, F Jeyapalan, K Muller, S O'Byrne, KJ
Citation: Al. Thomas et al., Gemcitabine and paclitaxel associated pneumonitis in non-small cell lung cancer: report of a phase I/II dose-escalating study, EUR J CANC, 36(18), 2000, pp. 2329-2334

Authors: Cox, G Walker, RA Andi, A Steward, WP O'Byrne, KJ
Citation: G. Cox et al., Prognostic significance of platelet and microvessel counts in operable non-small cell lung cancer, LUNG CANC, 29(3), 2000, pp. 169-177

Authors: Cox, G Jones, JL Walker, RA Steward, WP O'Byrne, KJ
Citation: G. Cox et al., Angiogenesis and non-small cell lung cancer, LUNG CANC, 27(2), 2000, pp. 81-100

Authors: Thomas, AL O'Byrne, K Steward, WP
Citation: Al. Thomas et al., Chemotherapy for upper gastrointestinal tumours, POSTG MED J, 76(896), 2000, pp. 321-327

Authors: O'Byrne, KJ Koukourakis, MI Giatromanolaki, A Cox, G Turley, H Steward, WP Gatter, K Harris, AL
Citation: Kj. O'Byrne et al., Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small cell lung cancer, BR J CANC, 82(8), 2000, pp. 1427-1432

Authors: Thomas, A Steward, WP
Citation: A. Thomas et Wp. Steward, Gemcitabine: A real major advance? Response, ANN ONCOL, 10(5), 1999, pp. NIL_2-NIL_2

Authors: Bramwell, VHC Steward, WP Nooij, M Whelan, J Craft, AW Grimer, RJ Taminau, AHM Cannon, SR Malcolm, AJ Hogendoorn, PCW Uscinska, B Kirkpatrick, AL Machin, D Van Glabbeke, MM
Citation: Vhc. Bramwell et al., Neoadjuvant chemotherapy with doxorubicin and cisplatin in malignant fibrous histiocytoma of bone: A European osteosarcoma intergroup study, J CL ONCOL, 17(10), 1999, pp. 3260-3269

Authors: Steward, WP
Citation: Wp. Steward, Marimastat (BB2516): Current status of development, CANC CHEMOT, 43, 1999, pp. S56-S60

Authors: O'Byrne, KJ Steward, WP
Citation: Kj. O'Byrne et Wp. Steward, The promise of improved drug delivery, CLIN SCI, 96(2), 1999, pp. 127-128

Authors: Cox, G Steward, WP O'Byrne, KJ
Citation: G. Cox et al., The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer, THORAX, 54(2), 1999, pp. 169-179

Authors: O'Byrne, K Steward, WP
Citation: K. O'Byrne et Wp. Steward, The role of chemotherapy in the treatment of adult soft tissue sarcomas, ONCOL-BASEL, 56(1), 1999, pp. 13-23
Risultati: 1-25 | 26-27